Authors:
Tovo, PA
Newell, ML
Coll, O
de Tejada, BM
Lanari, M
Bosi, I
Papa, I
Zanetti, A
Contreras, JR
Manzanares, A
Ramos, JT
Vegnente, A
Iorio, R
Fabris, C
Bandelloni, AM
Tibaldi, C
Ciria, LM
Palomba, E
Riva, C
Scolfaro, C
Buffolano, W
Scotese, I
Micco, A
Marcellini, M
Sartorelli, MR
Mattia, S
Bohlin, AB
Fischler, B
Lindgren, S
Lindh, G
Maccabruni, A
Pacati, I
Arlandi, L
Polywka, S
Butler, K
De Maria, A
Bassetti, D
Fioredda, F
Boni, S
Gotta, C
Mazza, A
Grosch-Worner, I
Sperling, CF
Quinti, I
Scaravelli, G
Cigna, P
Cilla, G
Echeverria, J
Souayah, H
Grossman, D
Levy, J
Bona, G
Mok, JYQ
Fontelos, PM
Arrieta, JV
Asensi-Botet, F
Otero, MC
Perez-Tamarit, D
Zuin, G
Saccani, B
Zuccotti, GV
Riva, E
Gamboni, A
Wejstal, R
Norkrans, G
Scherpbier, H
Mur, A
Vinolas, M
Extremera, AR
Roura, LC
Sanges, JMB
Leal, JAL
Rodriguez, A
Sarrion-Aunon, A
Corrias, A
Boucher, C
Hatzakis, A
Grella, P
Citation: Pa. Tovo et al., Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus, BR J OBST G, 108(4), 2001, pp. 371-377
Authors:
Westin, J
Lindh, M
Nenonen, N
Lagging, LM
Norkrans, G
Wejstal, R
Citation: J. Westin et al., Monitoring virological responses to interferon-ribavirin and interferon monotherapy of chronic hepatitis C re-treated due to relapse or non-response, SC J IN DIS, 33(2), 2001, pp. 110-115
Authors:
Lindh, M
Horal, P
Dhillon, AP
Norkrans, G
Citation: M. Lindh et al., Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B, J VIRAL HEP, 7(4), 2000, pp. 258-267
Authors:
Shev, S
Bjorkman, P
Norkrans, G
Foberg, U
Fryden, A
Lindh, G
Lindholm, A
Weiland, O
Widell, A
Citation: S. Shev et al., GBV-C/HGV infection in hepatitis C virus-infected deferred Swedish blood donors. (vol 54, pg 74, 1998), J MED VIROL, 61(3), 2000, pp. 409-409
Authors:
Gisslen, M
Svennerholm, B
Norkrans, G
Franzen, C
Sall, C
Svensson, R
Obergs, S
Hagberg, L
Citation: M. Gisslen et al., Cerebrospinal fluid and plasma viral load in HIV-1-infected patients with various anti-retroviral treatment regimens, SC J IN DIS, 32(4), 2000, pp. 365-369
Authors:
Reichard, O
Glaumann, H
Fryden, A
Norkrans, G
Wejstal, R
Weiland, O
Citation: O. Reichard et al., Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon, J HEPATOL, 30(5), 1999, pp. 783-787
Authors:
Westin, J
Lagging, LM
Wejstal, R
Norkrans, G
Dhillon, AP
Citation: J. Westin et al., Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection, LIVER, 19(3), 1999, pp. 183-187
Authors:
Westin, J
Lindh, M
Lagging, LM
Norkrans, G
Wejstal, R
Citation: J. Westin et al., Chronic hepatitis C in Sweden: Genotype distribution over time in different epidemiological settings, SC J IN DIS, 31(4), 1999, pp. 355-358
Authors:
Weiland, O
Braconier, JH
Fryden, A
Norkrans, G
Reichard, O
Uhnoo, I
Citation: O. Weiland et al., Influence of pre-treatment factors on outcome of interferon-alpha treatment of patients with chronic hepatitis C, SC J IN DIS, 31(2), 1999, pp. 115-118
Authors:
Lindh, M
Hannoun, C
Dhillon, AP
Norkrans, G
Horal, P
Citation: M. Lindh et al., Core promoter mutations and genotypes in relation to viral replication andliver damage in East Asian hepatitis B virus carriers, J INFEC DIS, 179(4), 1999, pp. 775-782
Authors:
Reichard, O
Norkrans, G
Fryden, A
Braconier, JH
Sonnerborg, A
Weiland, O
Citation: O. Reichard et al., Comparison of 3 quantitative HCV RNA assays - Accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C, SC J IN DIS, 30(5), 1998, pp. 441-446